The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery

Journal of Orthopaedic Trauma

Volumn 26, Issue 10, 2012, Pages 568-573

  Collinge, Cory A ^a   Kelly, Kevin C ^b   Little, Bert ^c   Weaver, Tara ^d   Schuster, Richard D ^e  

^a Harris Methodist Fort Worth Hospital   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c TARLETON STATE UNIVERSITY   (United States)

^d Orthopedic Specialty Associates   (United States)

^e Cook's Childrens's Hospital ^*  (United States)

Author keywords

anticoagulant; bleeding; clopidogrel; complication; fracture; hip; hip fracture; osteoporosis; Plavix

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE SCREW; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEMUR INTERTROCHANTERIC FRACTURE; FEMUR NECK FRACTURE; FEMUR PERTROCHANTERIC FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; HIP FRACTURE; HIP SURGERY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTRAMEDULLARY NAIL; INTRAMEDULLARY NAILING; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; BLOOD LOSS, SURGICAL; COHORT STUDIES; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; TREATMENT OUTCOME; WARFARIN;

EID: 84866897953     PISSN: 08905339     EISSN: 15312291     Source Type: Journal    
DOI: 10.1097/BOT.0b013e318240d70f     Document Type: Article

References (21)

1. Geiger J, Brich J, Honig-Liedl P, et al. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol. 1999;19:2007-2011.
2. Levy JH, Tanaka KA. The anticoagulated patient: strategies for effective blood loss management. Surgery. 2007;142:S71-S77.
3. Dolk T. Operation in hip fracture patients-analysis of the time factor. Injury. 1990;21:369-372.
4. Rogers FB, Shackford SR, Keller MS. Early fixation reduces morbidity and mortality in elderly patients with hip fractures from low-impact falls. J Trauma. 1995;39:261-265.
5. Zuckerman JD, Skovron ML, Koval KJ, et al. Postoperative complications and mortality associated with operative delay in older patients who have a fracture of the hip. J Bone Joint Surg Am. 1995;77:1551-1556.
6. Al-Ani AN, Samuelsson B, Tidermark J, et al. Early operation on patients with a hip fracture improved the ability to return to independent living. A prospective study of 850 patients. J Bone Joint Surg Am. 2008;90: 1436-1442.
7. Moran CG,Wenn RT, Sikand M, et al. Early mortality after hip fracture: is delay before surgery important? J Bone Joint Surg Am. 2005;87:483-489.
8. Shiga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth. 2008;55:146-154.
9. Lavelle WF, Demers Lavelle EA, Uhl R. Operative delay for orthopedic patients on clopidogrel (plavix): a complete lack of consensus. J Trauma. 2008;64:996-1000.
10. Harty JA, McKenna P, Moloney D, et al. Anti-platelet agents and surgical delay in elderly patients with hip fractures. J Orthop Surg (Hong Kong). 2007;15:270-272.
11. Johansen A, White J, Turk A. Clopidogrel therapy-implications for hip fracture surgery. Injury. 2008;39:1188-1190.
12. Anonymous. www.DSHS.state.tx.us. Accessed January 11, 2009.
13. Wolters U, Wolf T, Stutzer H, et al. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth. 1996;77: 217-222.
14. Nydick J, Farrell E, Marcantonio A, et al. The use of clopidogrel (Plavix) in patients undergoing nonelective orthopaedic surgery. J Orthop Trauma. 2010;24:383-386.
15. Inman DS, Michla Y, Partington PF. Perioperative management of trauma patients admitted on clopidogrel (Plavix). A survey of orthopaedic departments across the United Kingdom. Injury. 2007;38:625-630.
16. McGuire KJ, Bernstein J, Polsky D, et al. The 2004 Marshall Urist award: delays until surgery after hip fracture increases mortality. Clin Orthop Relat Res. 2004;428:294-301.
17. Palan J, Odutola A, White SP. Is clopidogrel stopped prior to hip fracture surgery-a survey of current practice in the United Kingdom. Injury. 2007;38:1279-1285.
18. Chen L, Bracey AW, Radovancevic R, et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2004;128:425-431.
19. Leong JY, Baker RA, Shah PJ, et al. Clopidogrel and bleeding after coronary artery bypass graft surgery. Ann Thorac Surg. 2005;80: 928-933.
20. Nurozler F, Kutlu T, Kucuk G, et al. Impact of clopidogrel on postoperative blood loss after non-elective coronary bypass surgery. Interact Cardiovasc Thorac Surg. 2005;4:546-549.
21. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to update the 1999 guidelines for coronary artery bypass graft surgery). Circulation. 2004; 110:1168-1176.